Other Issues:
previous
|
next
|
latest
|
archive
Volume 6(Suppl 9); 2004
Introduction
5α-Reductase Inhibition in the Treatment of LUTS and BPH: Update and Importance of Dual Inhibition of Types 1 and 2
Claus G Roehrborn
Rev Urol.
2004;
6
(Suppl 9)
: S1–S2.
PMCID:
PMC1472911
|
Full Text
|
PDF–55K
|
Treatment of LUTS and BPH
Pathophysiology, Epidemiology, and Natural History of Benign Prostatic Hyperplasia
Herbert Lepor
Rev Urol.
2004;
6
(Suppl 9)
: S3–S10.
PMCID:
PMC1472917
|
Abstract
|
Full Text
|
PDF–108K
|
5α-Reductase: History and Clinical Importance
Leonard S Marks
Rev Urol.
2004;
6
(Suppl 9)
: S11–S21.
PMCID:
PMC1472916
|
Abstract
|
Full Text
|
PDF–442K
|
The Clinical Benefits of Dutasteride Treatment for LUTS and BPH
Claus G Roehrborn
Rev Urol.
2004;
6
(Suppl 9)
: S22–S30.
PMCID:
PMC1472913
|
Abstract
|
Full Text
|
PDF–130K
|
Comparison of Clinical Trials With Finasteride and Dutasteride
J. Curtis Nickel
Rev Urol.
2004;
6
(Suppl 9)
: S31–S39.
PMCID:
PMC1472914
|
Abstract
|
Full Text
|
PDF–142K
|
The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy
Kevin M Slawin and Michael W Kattan
Rev Urol.
2004;
6
(Suppl 9)
: S40–S45.
PMCID:
PMC1472915
|
Abstract
|
Full Text
|
PDF–87K
|
AUA Guidelines and Their Impact on the Management of BPH: An Update
Steven A Kaplan
Rev Urol.
2004;
6
(Suppl 9)
: S46–S52.
PMCID:
PMC1472912
|
Abstract
|
Full Text
|
PDF–104K
|
Role of Primary Care Clinicians in the Diagnosis and Treatment of LUTS and BPH
Louis Kuritzky
Rev Urol.
2004;
6
(Suppl 9)
: S53–S59.
PMCID:
PMC1472918
|
Abstract
|
Full Text
|
PDF–90K
|
Other Issues:
previous
|
next
|
latest
|
archive
